Koopman, M <br/><br/>
Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Oct 2006 
 - 1523-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdl179  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Camptothecin--administration & dosage<br/>Capecitabine<br/>Carcinoma--drug therapy<br/>Colorectal Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Survival Analysis